Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
That was supposed to read, PMCB!!!!
I expect amazing success with this investment & the games being played with the share price will be HISTORY, as well as all the manipulative bashers with "no interest" (lol, not) in this company.
That's what I'm talking about... Boom!
Thank you joe!
Looooove, PMCB ??
I'm very excited about my investment here. If you are new, do yourself a favor & research Pharmacyte for yourself!
http://www.pharmacytebiotech.com/research-development/
This is an amazing company! I'm so happy I have an investment here...
Do your research please!
http://www.PharmaCyteBiotech.com.
March 27th. 3 pm
We will all see the truth soon enough lol
Long, strong, this is a noble investment on so many levels!
http://diabetesnewsjournal.com/2015/02/24/pharmacytes-proprietary-cell-technology-to-create-insulin-producing-cells-for-type-1-diabetes/
http://jnci.oxfordjournals.org/content/106/12/dju417.full
Another approach aims to make pancreatic cancer an operable disease. Using “Cell in a Box” technology developed by Austrianova, in Singapore, this cell therapy delivers ifosfamide locally to the cancer. Ifosfamide has previously shown promise as a chemotherapy against pancreatic cancer, but its effective dose was too toxic to give patients systemically. Instead, in the “Cell in the Box” approach, patients receive one-third of the usual dose of ifosfamide. “Cell in a Box” contains genetically modified cells that express the drug-metabolizing cytochrome P450 and converts the ifosfamide to its active form at the site of the tumor, according to CEO Brian Salmons, Ph.D. A catheter delivers the “Cell in a Box” capsule containing these cells to capillaries feeding the pancreas. This system of local delivery and activation greatly reduces side effects.
The European Medicines Agency fast-tracked this treatment, which is licensed to Nuvilex (Silver Spring, Md.). Nuvilex plans at least two new trials based on earlier phase I/II and phase II trials with a total of 27 patients with advanced pancreatic cancer.
In my opinion a person selling 7 million shares to receive a million cash in hand today, while leaving themselves over 5 million shares for the future is every persons dream! Good for Pat! Duh... wouldn't you do the same?
You have provided no substance to your claims here. I personally would not waste my time with a company I didn't believe in it... To each his/her own I guess. In my opinion Nuvilex is about to make history and those who do not sell their shares out of fear will be richly rewarded. Imo
Some buy, some sell. Whoever is holding when great news is released will win! Nothing has changed...yet.
LOL, It seems I have been holding so long here waiting for success I hadn't thought about my exit point!
Thank you Banks, Gowlfman & Ilhabela777... I always enjoy reading your posts & the input is very helpful!
arrrrrrghhhh, exit points? lol.... need help on this one ??
Great buying opportunity here at Nuvilex!
Just snatched up a few more! The potential for risk vs reward on investing in Nuvilex is too sweet to pass on, not worried at all!
proof positive, lol.... Go Nuvilex!
"Investors" think very differently from "Traders" ... & I have learned there is NO reasoning with "traders" who refuse to understand the concept of "Investing" ...
I am an "Investor" in NUVILEX!
oops on the verbiage but I think the point is clear... lol, go Mr. Briscoe!
I resemble that scenario lol, I believe patience is a virtue in an investor in lbsr
Thank you for keeping the info on nvlx honest!
"As discussed above, the Company acquired 100% of the shares and assets of Bio Blue Bird, including its Intellectual property related to the “Cell-in-a-Box ® live cell encapsulation
BBB... This tidbit just happened to be a major factor in my decision to invest in nvlx...
Nautilus Minerals was recently showcased on an episode of Innovations with Ed Begley Jr which aired on the Discovery Channel. To view the piece please click on the link
http://vimeo.com/85364387
There seems to be quite a bit of wrong information being posted on here...
The medical marijuana company associated with nvlx is NOT MM “services”, but MM SCIENCES.
http://www.medicalmarijuanasciences.com/
Medical Marijuana Sciences, Inc. (MMS), Nuvilex’s newest wholly-owned subsidiary, was established in early 2013 as a Nevada corporation.
The initial mission of MMS is to develop treatments, based on constituents of Cannabis, for two of the most serious and deadly forms of cancer,
namely brain and pancreatic cancers.
I agree Wendy, can this be "stickied" ... Lots of information here which showcases the many reasons why the nvlx longs are invested in this company at your fingertips! thanks Marlee!
Thank you!
Oops, the 10k?
Do you know when it's due out?
How exciting! Something good is about to happen IMO, not all late filings are due to negative events.
Thank you Rudy, awesome article!
New to nvlx? Please research everything posted here for yourself!
"Here's the big picture: NVLX will succeed or fail on its technology. I don't care about these coordinated attacks. I believe it's important for investors to understand how its done and why the best strategy is to decide if you like the company, and then stick with the investment if you believe in its merits.
http://www.otcjournal.com/archive/listserv/20140303-1.html
Nuvilex Read for yourself, then decide...
http://www.nuvilex.com/latest-news/118-nuvilex-scheduled-to-begin-preclinical-studies-in-early-august
“Translational Drug Development, LLC (TD2) will conduct the study.”
“Nuvilex's pancreatic cancer treatment, which combines the Cell-in-a-Box(R) live-cell encapsulation technology with the well-known anticancer drug ifosfamide, will be studied with the expectation that it can improve the quality of life of pancreatic cancer patients by slowing down the accumulation of ascites fluid in the abdomen.”
“The live cells are expected to arrive at TD2's facility in Scottsdale, Arizona, during the first week of August 2014. The preclinical study will commence almost immediately after their arrival.”
http://td2inc.com/
Nuvilex Retains TD2 to Conduct Preclinical and Clinical Studies...READ MORE >
"The Nuvilex team presents us with a new tool to employ against the symptoms and invasive properties of this very challenging cancer," said Daniel D. Von Hoff, M.D., Chief Development Officer of TD2. "Our Pancreatic Cancer Research Team (PCRT) colleagues are enthusiastic to begin clinical trials with this approach."
In commenting on TD2's work with Nuvilex, Kenneth L. Waggoner, Chief Executive Officer and President of Nuvilex, stated, "We are honored that TD2 and Dr. Von Hoff will play a pivotal role in the development of our treatment for patients with advanced pancreatic cancer that combines the proprietary Cell-in-a-Box live-cell encapsulation technology with the cancer drug ifosfamide. TD2 integrates world-class preclinical, clinical and regulatory expertise and provides unique drug development services aimed at minimizing the risk for its clients in the oncology drug development industry. In addition, access to the PCRT that is enabled by our association with TD2 will not only make Nuvilex's approach widely known, but should facilitate its development as we move forward. The sincere interest in our advanced pancreatic cancer treatment that has been shown by TD2 is particularly rewarding to all of us."
Long & Strong on my investment in this company!
That would be fantastic! Thank you :)
Thank you for clarifying this, I appreciate your posts here so much please keep the awesome information flowing here regarding nvlx!
After educating myself as to what the difference is between "naked" (illegal) shorting and just plain shorting I may file my own complaint to the sec.... Nvlx is a good company with great technology an does not deserve the interference from nefarious individuals...
Naked shorting of nvlx should be reported to the sec, NOT the company!
wish ihub had a "like" button! I like this very much!
The more I research the More confident I am in Nuvilex. Know what you are holding here in this company and see the blessing of your patience! The quote below was taken from there latest shareholder update...
"Nuvilex's financial position has become the strongest in the Company's history. Nuvilex is virtually debt-free and has access to all of the necessary capital it requires to meet both its short-term and long-term monetary commitments. In addition, Nuvilex has established credibility with accredited and institutional investors who have expressed a desire to fund Nuvilex's expansion plans under reasonable terms.
Peace to all "investors" here!
If nwbo has what we think it does, then all these "investigations" will flush all garbage down the proverbial can... Then this free publicity will eventually be very good! Wow what some people are willing to do just to get out of their short positions!
Away all day so forgive me if this is redundant...
AF references Dr. Buzdar for his latest NWBO “hit piece” … Check out the reviews the good Dr. received from his patients…
May 9th, 2012
"Unfortunately, hoping I would meet an overall caring doctor, he was nothing at all like what I hoped. He was condescending and lacked a show of respect overall.
Coincidently, comparing notes with a friend, the same thing had happened to her. I'm looking elsewhere."
http://www.vitals.com/doctors/Dr_Aman_Buzdar/reviews#ixzz355vbZ500